Immune Support Peptides

Immune support peptides encompass compounds that modulate innate and adaptive immune responses through distinct molecular mechanisms. Rather than broadly suppressing or stimulating immune activity, these peptides demonstrate targeted interactions with pattern recognition receptors, T-cell maturation pathways, and antimicrobial defense systems - characteristics that make them scientifically interesting for immunological research.

LL-37 is the only known human cathelicidin antimicrobial peptide (AMP), produced by epithelial cells and neutrophils in response to infection. Its mechanism involves direct disruption of microbial membranes, but research has expanded to reveal immunomodulatory roles including toll-like receptor modulation and promotion of dendritic cell maturation. Thymosin Alpha-1 (Tα1) is a thymic peptide that enhances T-cell differentiation, NK cell activity, and dendritic cell function, with a substantial body of clinical research in chronic infections and immune deficiency states. Thymulin is a zinc-dependent thymic hormone that regulates T-cell development and is studied for its role in thymic function decline with age. KPV is a tripeptide derived from the C-terminus of alpha-MSH that exerts anti-inflammatory effects through melanocortin receptor signaling, with particular research interest in intestinal inflammation models.

A unifying theme in this category is the distinction between immunostimulation and immunomodulation - these peptides do not uniformly amplify immune responses but rather restore balance in dysregulated states. This nuance is central to understanding their research applications and distinguishes them from non-specific immune stimulants.